These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25646114)

  • 1. Transcatheter valve therapy registry is a model for medical device innovation and surveillance.
    Carroll JD; Shuren J; Jensen TS; Hernandez J; Holmes D; Marinac-Dabic D; Edwards FH; Zuckerman BD; Wood LL; Kuntz RE; Mack MJ
    Health Aff (Millwood); 2015 Feb; 34(2):328-34. PubMed ID: 25646114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Rumsfeld JS; Holmes DR; Stough WG; Edwards FH; Jacques LB; Mack MJ
    JACC Cardiovasc Interv; 2015 Mar; 8(3):377-381. PubMed ID: 25703888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies.
    Carroll JD; Edwards FH; Marinac-Dabic D; Brindis RG; Grover FL; Peterson ED; Tuzcu EM; Shahian DM; Rumsfeld JS; Shewan CM; Hewitt K; Holmes DR; Mack MJ
    J Am Coll Cardiol; 2013 Sep; 62(11):1026-34. PubMed ID: 23644082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes at 1 year following transcatheter aortic valve replacement.
    Holmes DR; Brennan JM; Rumsfeld JS; Dai D; O'Brien SM; Vemulapalli S; Edwards FH; Carroll J; Shahian D; Grover F; Tuzcu EM; Peterson ED; Brindis RG; Mack MJ;
    JAMA; 2015 Mar; 313(10):1019-28. PubMed ID: 25756438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations and Recommendations for the Introduction of Objective Performance Criteria for Transcatheter Aortic Heart Valve Device Approval.
    Head SJ; Mylotte D; Mack MJ; Piazza N; van Mieghem NM; Leon MB; Kappetein AP; Holmes DR
    Circulation; 2016 May; 133(21):2086-93. PubMed ID: 27217434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Clinical Trial Experience on Transcatheter Aortic Valve Replacement Outcomes.
    McCarthy FH; Groeneveld PW; Kobrin D; McDermott KM; Wirtalla C; Desai ND
    Circ Cardiovasc Interv; 2015 Sep; 8(9):e002234. PubMed ID: 26286740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter aortic valve replacement: establishing a comprehensive program model for hybrid cardiac catheterization laboratories in the Department of Veterans Affairs.
    Speiser B; Dutra-Brice C
    Dimens Crit Care Nurs; 2014; 33(5):262-74. PubMed ID: 25144213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case studies on forecasting for innovative technologies: frequent revisions improve accuracy.
    Lerner JC; Robertson DC; Goldstein SM
    Health Aff (Millwood); 2015 Feb; 34(2):311-8. PubMed ID: 25646112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States.
    Acker MA; Pagani FD; Stough WG; Mann DL; Jessup M; Kormos R; Slaughter MS; Baldwin T; Stevenson L; Aaronson KD; Miller L; Naftel D; Yancy C; Rogers J; Teuteberg J; Starling RC; Griffith B; Boyce S; Westaby S; Blume E; Wearden P; Higgins R; Mack M
    Ann Thorac Surg; 2012 Dec; 94(6):2147-58. PubMed ID: 23153481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of new technology into clinical practice after FDA approval.
    Govil A; Hao SC
    J Interv Card Electrophysiol; 2016 Oct; 47(1):19-27. PubMed ID: 27565971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality and Safety in Health Care, Part XXIX: The Transcatheter Valve Therapy Registry.
    Harolds JA
    Clin Nucl Med; 2017 Nov; 42(11):853-854. PubMed ID: 28759529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary.
    Acker MA; Pagani FD; Stough WG; Mann DL; Jessup M; Kormos R; Slaughter MS; Baldwin T; Stevenson L; Aaronson KD; Miller L; Naftel D; Yancy C; Rogers J; Teuteberg J; Starling RC; Griffith B; Boyce S; Westaby S; Blume E; Wearden P; Higgins R; Mack M
    Ann Thorac Surg; 2012 Dec; 94(6):e163-8. PubMed ID: 23153480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States.
    Acker MA; Pagani FD; Stough WG; Mann DL; Jessup M; Kormos R; Slaughter MS; Baldwin T; Stevenson L; Aaronson KD; Miller L; Naftel D; Yancy C; Rogers J; Teuteberg J; Starling RC; Griffith B; Boyce S; Westaby S; Blume E; Wearden P; Higgins R; Mack M
    Circ Heart Fail; 2013 Jan; 6(1):e1-e11. PubMed ID: 23149497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational dispersion for the introduction of transcatheter valve therapy.
    Mack MJ; Holmes DR
    JAMA; 2011 Nov; 306(19):2149-50. PubMed ID: 22089724
    [No Abstract]   [Full Text] [Related]  

  • 17. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary.
    Acker MA; Pagani FD; Stough WG; Mann DL; Jessup M; Kormos R; Slaughter MS; Baldwin T; Stevenson L; Aaronson KD; Miller L; Naftel D; Yancy C; Rogers J; Teuteberg J; Starling RC; Griffith B; Boyce S; Westaby S; Blume E; Wearden P; Higgins R; Mack M
    Circ Heart Fail; 2013 Jan; 6(1):145-50. PubMed ID: 23149496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: summary assessment of the California Technology Assessment Forum.
    Tice JA; Sellke FW; Schaff HV
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):482-91.e6. PubMed ID: 24252939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: data from the TAVI National Registry 2010-2011.
    Sabaté M; Cánovas S; García E; Hernández Antolín R; Maroto L; Hernández JM; Alonso Briales JH; Muñoz García AJ; Gutiérrez-Ibañes E; Rodríguez-Roda J;
    Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):949-58. PubMed ID: 24774108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Vascular Implant Surveillance and Interventional Outcomes (VISION) Coordinated Registry Network: An effort to advance evidence evaluation for vascular devices.
    Tsougranis G; Eldrup-Jorgensen J; Bertges D; Schermerhorn M; Morales P; Williams S; Bloss R; Simons J; Deery SE; Scali S; Roche-Nagle G; Mureebe L; Mell M; Malas M; Pullin B; Stone DH; Malone M; Beck AW; Wang G; Marinac-Dabic D; Sedrakyan A; Goodney PP
    J Vasc Surg; 2020 Dec; 72(6):2153-2160. PubMed ID: 32442604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.